Calcium-D supplementation effects in sugar control in gestational diabetes
Phase 2
Recruiting
- Conditions
- Gestational diabetes.Diabetes mellitus in pregnancy, unspecified
- Registration Number
- IRCT20100102002954N11
- Lead Sponsor
- Shahroud University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 84
Inclusion Criteria
GDM test positive in 26-24 weeks of pregnancy
Pregnant women without the previous diagnosis of glucose intolerance
Satisfaction in rasarach
Exclusion Criteria
Previous diabetes history
Premature rupture of the membrane
Pausing suddenly of corion
Pregnancy hypertension
Eclampsia
Chronic hypertension
Hypothyroidism
Need to start insulin therapy during the intervention
Dissatisfaction in rasarach
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood glucose measurement. Timepoint: At the beginning of the study and 3 months after starting Calcium-D intake. Method of measurement: Laboratory method of sugar measurement.;Measuring glycosylated hemoglobin. Timepoint: At the beginning of the study and 3 months after the start of Calcium-D intake. Method of measurement: Laboratory method for glycosylated hemoglobin mesurement.
- Secondary Outcome Measures
Name Time Method Cratenin measurement. Timepoint: At the beginning of the study and 3 months after Calcium-D intake. Method of measurement: laboratory method of Cratenin measurement.;Urea measurement. Timepoint: At the beginning of the study and 3 months after Calcium-D intake. Method of measurement: laboratory method of urea measurement.